Energetics and structural characterization of the "DFG-flip'' conformational transition of B-RAF kinase: a SITS molecular dynamics study

被引:17
作者
Shao, Qiang [1 ]
Xu, Zhijian [1 ]
Wang, Jinan [1 ]
Shi, Jiye [2 ]
Zhu, Weiliang [1 ]
机构
[1] Chinese Acad Sci, Drug Discovery & Design Ctr, Shanghai Inst Mat Med, Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China
[2] UCB Biopharma SPRL, Chemin Foriest, Braine Lalleud, Belgium
基金
中国国家自然科学基金;
关键词
AIDED DRUG DESIGN; RECEPTOR FLEXIBILITY; BIOLOGICAL MOLECULES; PROTEIN FLEXIBILITY; INTRINSIC DYNAMICS; SIMULATION METHOD; FORCE-FIELD; C-ABL; ACTIVATION; INHIBITORS;
D O I
10.1039/c6cp06624k
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
B-RAF protein kinase is a promising target to treat malignant melanoma. The kinase activity of B-RAF is regulated by a "DFG-flip'' conformational transition between functional DFG-in and DFG-out states. The difficulty in resolving the activation loop in crystal structures and the even greater difficulty in experimentally capturing high-energy-level transient structures render elusive the molecular mechanism of the B-RAF functional conformational transition. Here, a homology modeling technique and an enhanced sampling molecular dynamics simulation were used to identify and energetically characterize the conformational transition pathway of B-RAF on a multi-dimensional free-energy landscape. The results reveal that the conformational transition is a two-state transition, with the evaluated free-energy barrier comparable to those of other kinds of kinases as reported in the previous literature. Hydrophobic interactions between activation loop and neighboring segments are suggested to dominate the conformational transition and determine the free-energy barrier. The detailed analysis of hydrophobic interactions involved in the conformational transition may show a suitable pathway for the development of the B-RAF inhibitor.
引用
收藏
页码:1257 / 1267
页数:11
相关论文
共 72 条
  • [21] MODELLER: Generation and refinement of homology-based protein structure models
    Fiser, A
    Sali, A
    [J]. MACROMOLECULAR CRYSTALLOGRAPHY, PT D, 2003, 374 : 461 - 491
  • [22] Guilty as charged: B-RAF is a human oncogene
    Garnett, MJ
    Marais, R
    [J]. CANCER CELL, 2004, 6 (04) : 313 - 319
  • [23] A coupled equilibrium shift mechanism in calmodulin-mediated signal transduction
    Gsponer, Joerg
    Christodoulou, John
    Cavalli, Andrea
    Bui, Jennifer M.
    Richter, Barbara
    Dobson, Christopher M.
    Vendruscolo, Michele
    [J]. STRUCTURE, 2008, 16 (05) : 736 - 746
  • [24] Accelerated molecular dynamics: A promising and efficient simulation method for biomolecules
    Hamelberg, D
    Mongan, J
    McCammon, JA
    [J]. JOURNAL OF CHEMICAL PHYSICS, 2004, 120 (24) : 11919 - 11929
  • [25] Potent and selective pyrazole-based inhibitors of B-Raf kinase
    Hansen, Joshua D.
    Grina, Jonas
    Newhouse, Brad
    Welch, Mike
    Topalov, George
    Littman, Nicole
    Callejo, Michele
    Gloor, Susan
    Martinson, Matthew
    Laird, Ellen
    Brandhuber, Barbara J.
    Vigers, Guy
    Morales, Tony
    Woessner, Rich
    Randolph, Nikole
    Lyssikatos, Joseph
    Olivero, Alan
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (16) : 4692 - 4695
  • [26] Parallel tempering algorithm for conformational studies of biological molecules
    Hansmann, UHE
    [J]. CHEMICAL PHYSICS LETTERS, 1997, 281 (1-3) : 140 - 150
  • [27] Illuminating the mechanistic roles of enzyme conformational dynamics
    Hanson, Jeffrey A.
    Duderstadt, Karl
    Watkins, Lucas P.
    Bhattacharyya, Sucharita
    Brokaw, Jason
    Chu, Jhih-Wei
    Yang, Haw
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (46) : 18055 - 18060
  • [28] Molecular dynamics simulations
    Hansson, T
    Oostenbrink, C
    van Gunsteren, WF
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2002, 12 (02) : 190 - 196
  • [29] Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.3.CO
  • [30] 2-I